A phase II study of belinostat [PXD 101] in combination with bortezomib [Velcade] in patients with relapsed, refractory multiple myeloma
Phase of Trial: Phase I/II
Latest Information Update: 08 Jul 2015
At a glance
- Drugs Belinostat (Primary) ; Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- Sponsors TopoTarget
- 06 Aug 2007 Interim safety data have been announced.
- 29 Mar 2006 New trial record.